1143 The Effect of Medication in OSA Patients with Allergic Rhinitis

Wednesday, 14 October 2015
Hall D1 Foyer (Floor 3) (Coex Convention Center)

Young Seok Byun, MD , ORL-Hns, Kyung Hee Medical Center, Seoul, South Korea

Sung-Hwa Dong, MD , ORL-Hns, Kyung Hee Medical Center, Seoul, South Korea

Tae Kyung Koh, MD , ORL-Hns, Kyung Hee Medical Center, Seoul, South Korea

Chul Kwon, MD , ORL-Hns, Kyung Hee Medical Center, Seoul, South Korea

Kun Hee Lee, MD, PhD , ORL-Hns,, Kyung Hee University Hospital at Gangdong, Seoul, South Korea

Joong-Saeng Jo, MD, PhD , ORL-Hns, Kyung Hee Medical Center, Seoul, South Korea

Sung Wan Kim, MD, PhD , ORL-Hns, Kyung Hee Medical Center, Seoul, South Korea

OBJECTIVE

Allergic rhinitis occurs at 10-40% in the world's population and it cause runny nose, sneezing, itching and qualitative degraded sleep disorder which are causing the failure of social life. Allergic rhinitis can be associated with patient of obstructive sleep apnea. The aim of this study was to investigate the impact of allergic rhinitis on obstructive sleep apnea and the change of the symptoms of obstructive sleep apnea after allergic rhinitis treatment.

METHOD

We examined patients who diagnosed with obstructive sleep apnea using polysomnography in our sleep clinic. All the patient was examined by allergy skin testing and diagnosed with allergic rhinitis. Patients were group of OSA with AR. We did Allergic rhinitis medical treatment for 2 weeks before OSA treatment.

 We did the survey of Visual analogue scale, Epworth Sleepiness Scale, Chalder Fatigue Scale, Daily Hassles Scale, Conner-Davidson Resilience Scale, Rhinoconjunctivitis Quality of Life Questionnaire  before and after Allergic rhinitis treatment.

RESULTS

OSA-AR group was 14 pateints. Age ranged from 17 to 66 years old and mean age 27. prior treatment, OSA-AR group score was less than average in VAS(sleep time, wake time), ESS, CFS, DHS, CD-RISC, RQLQ examination and TNSS, which associated with rhinitis in RQLQ, showed less than average except nasal obstruction in OSA-AR . VAS (sleep time, wake time) and RQLQ in patients who underwent 2weeks medical treatment showed statistically significant difference after treatment. (sleep time P = 0.001, wake time P = 0.000,  RQLQ P=.011) The average scores of ESS, CFS, DHS, CD-RISC, RQLQ, TNSS was lower but no significant difference after treatment than before treatment.

CONCLUSION

We could find out  Allergic rhinitis treatment contributes to improve subjective

symptoms and QOL of patients in OSA-AR treatment patients.

but considering lower number of subject, further investigation should be performed.